Outlook Therapeutics Inc (OTLK)

[pfelgueiras]

$OTLK - My Thoughts Regarding the Conversion of the $31 Million Loan into OTLK Shares and Its Impact on the OTLK-Buyout Date

If the buyer in the OTLK-Buyout does not want Streeterville to convert the $31.8 Million loan into OTLK shares, he will have to announce the Buyout in January 2023 for this to be completed by March 30, 2023.

The Conversion can take place from April 01, 2023 if the daily volume weighted average price of the OTLK Common Stock on Nasdaq equals or exceeds $2.50 per share for a period of 30 consecutive trading days.

If this happens Streeterville has the right to convert all or any portion of the outstanding balance under the Note into shares of Common Stock at a conversion price of $2.00 per share.